View Item 

Show simple item record

Coexisting depressive symptoms do not limit the benefits of chronic neuromodulation: A study of over 200 patients
dc.contributor.authorKillinger, Kim A.
dc.contributor.authorFergus, Jonathan
dc.contributor.authorEdwards, Luke
dc.contributor.authorBoura, Judith A.
dc.contributor.authorBartley, Jamie
dc.contributor.authorGupta, Priyanka
dc.contributor.authorTomakowsky, Janice
dc.contributor.authorGilleran, Jason
dc.contributor.authorPeters, Kenneth M.
dc.date.accessioned2018-04-04T18:50:31Z
dc.date.available2019-04-01T15:01:10Zen
dc.date.issued2018-02
dc.identifier.citationKillinger, Kim A.; Fergus, Jonathan; Edwards, Luke; Boura, Judith A.; Bartley, Jamie; Gupta, Priyanka; Tomakowsky, Janice; Gilleran, Jason; Peters, Kenneth M. (2018). "Coexisting depressive symptoms do not limit the benefits of chronic neuromodulation: A study of over 200 patients." Neurourology and Urodynamics 37(2): 815-822.
dc.identifier.issn0733-2467
dc.identifier.issn1520-6777
dc.identifier.urihttps://hdl.handle.net/2027.42/142918
dc.publisherWiley Periodicals, Inc.
dc.subject.otheroveractive
dc.subject.otherurinary bladder
dc.subject.otherdepressive symptoms
dc.subject.otherimplantable neurostimulators
dc.titleCoexisting depressive symptoms do not limit the benefits of chronic neuromodulation: A study of over 200 patients
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142918/1/nau23356_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142918/2/nau23356.pdf
dc.identifier.doi10.1002/nau.23356
dc.identifier.sourceNeurourology and Urodynamics
dc.identifier.citedreferenceVrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder—A systematic review. J Psychosom Res. 2015; 78: 295 – 108.
dc.identifier.citedreferenceLevin PJ, Siddiqui NY, Wu JM, Amundsen CL. Psychosocial factors related to the use of InterStim for the treatment of refractory overactive bladder. Fem Pelvic Med Reconstruc Surg. 2014; 20: 272 – 275.
dc.identifier.citedreferenceLai HH, Shen B, Rawal A, Vetter J. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016; 16: 60.
dc.identifier.citedreferenceDrossaerts J, Vrijens D, Leue C, Schilders I, Van Kerrebroeck P, van Koeveringe G. Screening for depression and anxiety in patients with storage or voiding dysfunction: a retrospective cohort study predicting outcome of sacral neuromodulation. Neurourol Urodynam. 2016; 35: 1011 – 1016.
dc.identifier.citedreferenceAmend B, Khalil M, Kessler TM, Sievert KD. How does sacral modulation work best? Placement and programming techniques to maximize efficacy. Curr Urol Rep. 2011; 12: 327 – 335.
dc.identifier.citedreferencePeters KM, Killinger KA, Boguslawski BM, Boura JA. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodynam. 2010; 29: 1267 – 1271.
dc.identifier.citedreferenceSiddiqui NY, Wu JM, Amundsen CL. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodynam. 2010; 29: S18 – S23.
dc.identifier.citedreferenceSiegel S, Noblett K, Mangel J, et al. Three‐year follow‐up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. 2016; 94: 57 – 63.
dc.identifier.citedreferencevan Balken MR, Vergunst H, Bemelmans BL. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol. 2006; 49: 360 – 365.
dc.identifier.citedreferenceRosenberger PH, Jokl P, Ickovics J. Psychosocial factors and surgical outcomes: an evidence based literature review. J Am Acad Orthop Surg. 2006; 14: 397 – 405.
dc.identifier.citedreferenceKroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mohdad AH. The PHQ‐8 as a measure of current depression in the general population. J Affect Disord. 2009; 114: 163 – 113.
dc.identifier.citedreferenceSpitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD‐7. Arch Intern Med. 2006; 166: 1092 – 1097.
dc.identifier.citedreferenceTully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res. 2008; 64: 285 – 290.
dc.identifier.citedreferenceBurg MM, Benedetto MC, Rosenberg R, Soufer R. Pre‐surgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery. Psychosom Med. 2003; 65: 111 – 118.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
nau23356_am.pdf
Size:
323.8KB
Format:
PDF
View/Open
Name:
nau23356.pdf
Size:
137.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.